Piper Jaffray Starts Celyad SA (CYAD) at Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. SPY
2. EYPT
3. CRWV
4. SLN
5. SLGN
6. IRON
7. MANE
8. ABBV
9. AIBT
10. PNB:IN

Go back to Piper Jaffray Starts Celyad SA (CYAD) at Overweight

UPDATE: UBS Starts Celyad SA (CYAD) at Buy

July 14, 2015 8:22 AM EDT

(Updated - July 14, 2015 8:43 AM EDT)

UBS initiates coverage on Celyad SA (NASDAQ: CYAD) with a Buy rating and a price target of $82.00.

Analyst Andrew Peters commented, "We are initiating coverage on Celyad SA with a Buy rating and $82 price target following an extensive analysis of the phase-3 C-Cure program in heart failure as well as the NK-based CAR-T technology currently in phase-1 trials. We believe initial proofof-concept data from... More